Bellone M, Pradelli L, Tavarozzi R, et al. Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis. Farmeconomia. Health Economics and Therapeutic Pathways. 2022;23(1). https://doi.org/10.7175/fe.v23i1.1532